T1	Participants 45 216	hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck
T3	Participants 1016 1028	101 patients
T2	Participants 611 899	Of 130 patients with locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck (SCC H&N) who entered a prospective, randomised trial, 101 patients received 50.6 Gy to a portion of their spinal cord and survived > 1 year following the beginning of therapy.
T4	Participants 281 363	after a cervical spinal cord dose of 50.6 Gy given via 1.1 Gy b.i.d. fractionation
